Miraculins Inc. will receive the Life Science Company of the Year Award from the Life Science Association of Manitoba for 2012.
Last year the company successfully launched its PreVu skin cholesterol test in pharmacies across the country.
The technology is a revolutionary new coronary artery disease risk assessment technology that measures cholesterol levels in a patient’s skin non-invasively, painlessly and without the need for fasting.
Miraculins is also working with Alere Inc., one of the world’s largest diagnostic companies, on a suite of biomarkers to aid in the early detection of preeclampsia, a devastating disease of pregnancy.
The award is presented annually to a private sector company based in Manitoba that has made a positive impact on the life sciences sector in the past year and is active in paving the road toward future wealth and job creation in the province. Past winners include IMRIS, Biovail and Cangene.
LSAM presents the award at a ceremony on February 13, 2013.